We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Rapamycin Lotion Reduces Facial Tumors Caused by Tuberous Sclerosis

News   May 24, 2018 | Original story from University of Texas Health

 
Rapamycin Lotion Reduces Facial Tumors Caused by Tuberous Sclerosis

Working on a promising treatment for facial tumors tied to tuberous sclerosis complex, from the left, are Adelaide Hebert, M.D.; John Slopis, M.D.; Mary Kay Koenig, M.D.; Joshua Samuels, M.D., M.P.H.; and Hope Northrup, M.D. All are from McGovern Medical School at UTHealth in Houston with the exception of Slopis, who is with The University of Texas MD Anderson Cancer Center. Credit: Maricruz Kwon, UTHealth

 
 
 

RELATED ARTICLES

Powerful Psychedelic Compound Models Near-Death Experiences in the Brain

News

Potent psychedelic DMT mimics near-death experience in the brain

READ MORE

Scrap the Scratching: New Way to Treat an Itch

News

Two receptors in the spinal cord and the right experimental drug: Researchers at the University of Zurich have discovered a new approach that suppresses itch.

READ MORE

Cancer-Fighting Drugs Also Help Plants Fight Disease

News

Cancer-fighting drugs can help plants fight disease. This discovery could help scientists develop new pathways for plants to battle infection.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE